Author: cyril
Sorry, no results were found.
Servier signed a definitive agreement to acquire Symphogen
Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company, to boost its antibody capabilities and leverage its R&D pipeline
06/04/2020